Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editors-in-Chief, Associate Editors and Section Editors for this issue.
Linda S. Sher
Dr Linda Sher is Professor, Division of Hepatobiliary Surgery and Abdominal Organ Transplantation and the Chief, Division of Clinical Research in the Department of Surgery at Keck School of Medicine, University of Southern California (USC), USA. Dr Sher completed her medical school training and surgical residency at Mount Sinai School of Medicine in New York, following which she completed a fellowship training in Liver and Kidney Transplantation at the University of Pittsburgh, USA. After completing her fellowship in 1988, Dr Sher was involved in the establishment of two liver transplant programs in Los Angeles prior to joining the USC program in 2001. Dr Sher has participated in and overseen over 100 research projects and is currently very active in the development of the clinical and basic science research components of the USC Abdominal Organ Transplantation Program. She has numerous publications on immunosuppression, chronic rejection, disease recurrence, infection, and hepatobiliary surgery.
Dr Sher is one of the original editors of Current Opinion in Organ Transplantation and has endeavored over the years to provide the reader with an up to date overview of the entire field of organ transplantation.
Josep M. Grinyó
Dr Josep Grinyó, MD, PhD, is Emeritus Professor of Medicine at the University of Barcelona. Dr Grinyó's research work on renal transplantation has been focused on immunosuppression, ischemia-reperfusion injury and chronic allograft damage in the clinical setting and in experimental animal models.
He has hold more than 60 competitive research projects and he has authored more than 340 articles and given more than 250 invited lectures.
He has acted as associate editor and reviewer in the top ranked journals in his field of expertise (AJT, CJASN, JASN, NEJM, NDT, TI, Lancet). He has been member of the councils of the scientific societies and chair of several scientific programs committees of congresses of these societies (TTS, ERA-EDTA, ESOT, ISN). He is member of several steering committees and DSMBs of international research consortiums on cell therapy, biomarker-driven immunosuppression, treatment of autoimmune nephritis and organ preservation. He is reviewer of competitive research applications for research organisations in Spain, Belgium, Germany, France (Inserm), Argentine, Austria, USA and UK (MRC, EME Experts).
Dr Kupiec-Weglinski is the Director of Dumont-University of California, Los Angeles (UCLA) Transplant Research Laboratories in Los Angeles, USA. He is a Distinguished Professor of Surgery, and Vice-Chairman (Research), Department of Surgery, at the David Geffen School of Medicine at UCLA. He holds the Inaugural Paul I. Terasaki Endowed Chair in Surgery. Dr Kupiec-Weglinski's interests focus on the immunobiology of organ ischemia-reperfusion injury, host sensitization, and tolerance induction in transplant recipients. He has authored over 400 papers. His research for the last 32 years has been funded by National Institute of Health (NIH). He served as standing member of the Transplantation, Tolerance and Tumor Immunology (TTT) NIH Study Section, as member of the board of directors of American Society of Transplantation, recipient of AST/Astellas Established Investigator Award in Basic Transplant Research, as well as of The Transplantation Society (TTS) Awards for Outstanding Achievements in Basic Science; and for Mentorship or Education and Training in Transplantation. He holds the Honorary Doctorate (“Honoris Causa”) from Medical University of Warsaw, and is the Foreign Member of Polish Academy of Sciences and Polish Academy of Arts and Sciences.
Valeria R. Mas
Dr Valeria R. Mas, PhD is a molecular and cellular immunologist that serves as tenured Professor of Surgery and Division Head of the Division of Surgical Sciences at the University of Maryland. Dr. Mas was the Director of the Transplant Genomics Laboratory at Virginia Commonwealth University until 2011 and she went on to become a tenured Associate Professor of Research Surgery at the University of Virginia, where she directed the Translational Genomics Transplant Laboratory and was Co-Director of Transplant Research. She is the founder and former Director of the Transplant Research Institute that is part of the Methodist University Transplant Institute associated with University of Tennessee Health Science Center. Dr. Mas has been conducting studies in genomics and proteomics related to kidney and liver transplant recipients during the last 20 years. Her research projects are mainly focused to: (1) evaluate the molecular pathways that associate with graft fibrosis development and loss of function post-kidney transplantation, (2) test the effects of organ donor biology in short-and long-term outcomes post-transplantation, and (3) identify early biomarkers that distinguish those organs at high risk of post-transplant dysfunction. She uses integrative approaches (proteomics, epigenetics, transcriptomics, and bioinformatics) for understanding the role of immunological and non-immunological factors in transplantation outcomes. As a PI and Coinvestigator, she has been funded by NIH during the last 15 years and has more than 100 peer reviewed publications. She has received investigator awards from the American Transplant Society, from the International Liver Transplant Society, and from The Transplantation Society. She was elected Councilor of the International Liver Transplant Society and serves as an ad hoc reviewer in multiple NIH study sections and is a member of NIDDK PBKD study section.
Michael L. Volk
Dr Michael L. Volk is the Chief of Gastroenterology and Hepatology, and Medical Director of Liver Transplantation at Loma Linda University. He is triple board certified in Transplant Hepatology, Gastroenterology, and Internal Medicine, and has been frequently selected by Best Doctors as among the top Hepatologists in the country.
Prior to moving to Loma Linda, Dr Volk was Director of the Liver Tumor Program at the University of Michigan. He is a former Robert Wood Johnson Clinical Scholar, with a funded research program that focuses on management of cirrhosis and organ allocation for liver transplantation. He has published >100 research articles, reviews, and book chapters.
Since moving to Loma Linda in 2015, Dr. Volk has helped quadruple the size of the liver transplant program, from 25/year to >100/year. He has grown the GI division from 8 faculty to 17 and established numerous satellite clinical locations including an academic-private partnership in an ambulatory surgery center. He has introduced numerous new clinical services and established a multidisciplinary Digestive Disease Center.
In his free time, he enjoys hiking and biking with his wife Corrie and two boys Alexander and Sebastian.
Prof. Uwe Heemann is a graduate from Bochum Medical University where he received his MD. He worked a fellow at the University Hospital Essen as well as at the Brigham Hospital in Boston. Currently he is Director of the Department of Nephrology, Klinikum rechts der Isar, Technical University Munich. Prof. Heemann is nationally and internationally recognized as leader in the field of kidney transplantation. He is a Past-President of the German Society of Transplantation, Member of the Board of Eurotransplant, Chair of the Kidney Advisory Committee of Eurotransplant and served as member of the DESCARTES group. His current activities focus on transplantation as well as the reduction of mortality in the field of dialysis.
He has published more than 350 articles cited in medline as well as a multitude of monographies and books, was principal investigator in multiple international and national trials and served as advisor for various scientific groups as well as pharmaceutical companies.
He has published in prestigious journals including Journal of Clinical Investigation, Kidney International, Transplantation, Circulation, Hypertension and Journal of the American Society of Nephrology.
In addition, he serves on numerous international journals, lectures at universities around the world and has facilitated the careers of national and international fellows to high academic positions.